Two Sigma Investments
BBLG

Two Sigma Investments’s Bone Biologics BBLG Stock Holding History

Two Sigma Investments’s Portfolio BBLG Stock Details BBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,083
Closed -$16.1K – 4585
2025
Q4 		$16.1K Buy
+11,083
New +$22.1K ﹤0.01% 4008

Other funds holding BBLG

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's BBLG Position: Q1 2026 in Review

Two Sigma Investments sold out of Bone Biologics (BBLG) in Q1 2026, closing a stake of 11,083 shares — an estimated $16.1K sold.

Two Sigma Investments first reported a position in BBLG in Q4 2025 and held it in 1 quarter. The position peaked at $16.1K in Q4 2025. 3 funds tracked by Wall St. Rank hold BBLG as of Q1 2026.

  • Two Sigma Investments reported no remaining Bone Biologics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 11,083 Bone Biologics shares in Q1 2026, an estimated $16.1K.
  • Two Sigma Investments first reported a position in Bone Biologics in Q4 2025 and held it in 1 quarter.
  • Two Sigma Investments's Bone Biologics position peaked at $16.1K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Bone Biologics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.